Advances in ultrasound mediated gene therapy using microbubble contrast agents

Theranostics

Volumn 2, Issue 12, 2012, Pages 1208-1222

  Sirsi, Shashank R ^a   Borden, Mark A ^a  

^a UCB 450   (United States)

Author keywords

Cavitiation; Sonoporation; Targeted image guided DNA delivery

Indexed keywords

ANDROGEN RECEPTOR; CONTRAST MEDIUM; GREEN FLUORESCENT PROTEIN; OLIGODEOXYNUCLEOTIDE; PARVOVIRUS VECTOR; PLASMID DNA; VIRUS DNA;

ANALYTICAL PARAMETERS; BLOOD VESSEL PERMEABILITY; CELL MEMBRANE PERMEABILITY; ENDOCYTOSIS; ENZYME REGULATION; GENE DELIVERY SYSTEM; GENE TARGETING; GENE THERAPY; HETEROZYGOTE; IN VIVO STUDY; MICROBUBBLE; MODULATION; NONHUMAN; PARTICLE SIZE; REVIEW; SONOPORATION; ULTRASOUND; VIRUS HYBRID;

CAVITIATION; SONOPORATION; TARGETED IMAGE-GUIDED DNA DELIVERY.;

ANIMALS; BLOOD VESSELS; CONTRAST MEDIA; DNA; GENETIC THERAPY; HUMANS; MICROBUBBLES; ULTRASONICS;

EID: 84883151007     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.4306     Document Type: Review

References (96)

1. Sirsi S, Borden M. Microbubble Compositions, Properties and Biomedical Applications. Bubble Sci Eng Technol. 2009; 1: 3-17.
2. Chadderdon SM, Kaul S. Molecular imaging with contrast enhanced ultrasound. J Nucl Cardiol. 2010; 17: 667-77.
3. Inaba Y, Lindner JR. Molecular imaging of disease with targeted contrast ultrasound imaging. Transl Res. 2012; 159: 140-8.
4. Kiessling F, Bzyl J, Fokong S, Siepmann M, Schmitz G, Palmowski M. Targeted ultrasound imaging of cancer: an emerging technology on its way to clinics. Curr Pharm Des. 2012; 18: 2184-99.
5. Kiessling F, Fokong S, Koczera P, Lederle W, Lammers T. Ultrasound microbubbles for molecular diagnosis, therapy, and theranostics. J Nucl Med. 2012; 53: 345-8.
6. Kaufmann BA, Lindner JR. Molecular imaging with targeted contrast ultrasound. Curr Opin Biotechnol. 2007; 18: 11-6.
7. Lindner JR. Molecular imaging with contrast ultrasound and targeted microbubbles. J Nucl Cardiol. 2004; 11: 215-21.
8. Moestue SA, Gribbestad IS, Hansen R. Intravascular Targets for Molecular Contrast-Enhanced Ultrasound Imaging. International Journal of Molecular Sciences. 2012; 13: 6679-97.
9. Geis NA, Katus HA, Bekeredjian R. Microbubbles as a vehicle for gene and drug delivery: current clinical implications and future perspectives. Curr Pharm Des. 2012; 18: 2166-83.
10. Wei K. Future applications of contrast ultrasound. J Cardiovasc Ultrasound. 2010; 19: 107-14.
11. Qin S, Caskey CF, Ferrara KW. Ultrasound contrast microbubbles in imaging and therapy: physical principles and engineering. Phys Med Biol. 2009; 54: R27-57.
12. Yi Y, Noh MJ, Lee KH. Current advances in retroviral gene therapy. Curr Gene Ther. 2011; 11: 218-28.
13. Kappes JC, Wu X. Safety considerations in vector development. Somat Cell Mol Genet. 2001; 26: 147-58.
14. Nair V. Retrovirus-induced oncogenesis and safety of retroviral vectors. Curr Opin Mol Ther. 2008; 10: 431-8.
15. Yi Y, Hahm SH, Lee KH. Retroviral gene therapy: safety issues and possible solutions. Curr Gene Ther. 2005; 5: 25-35.
16. Patil SD, Rhodes DG, Burgess DJ. DNA-based therapeutics and DNA delivery systems: a comprehensive review. AAPS J. 2005; 7: E61-77.
17. Liu C, Zhang N. Nanoparticles in gene therapy principles, prospects, and challenges. Prog Mol Biol Transl Sci. 2011; 104: 509-62.
18. Nishikawa M, Huang L. Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum Gene Ther. 2001; 12: 861-70.
19. Manickan E, Smith JS, Tian J, Eggerman TL, Lozier JN, Muller J, et al. Rapid Kupffer cell death after intravenous injection of adenovirus vectors. Mol Ther. 2006; 13: 108-17.
20. Klibanov AL. Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications. Invest Radiol. 2006; 41: 354-62.
21. Korpanty G, Chen S, Shohet RV, Ding J, Yang B, Frenkel PA, et al. Targeting of VEGF-mediated angiogenesis to rat myocardium using ultrasonic destruction of microbubbles. Gene Ther. 2005; 12: 1305-12.
22. Tsunoda S, Mazda O, Oda Y, Iida Y, Akabame S, Kishida T, et al. Sonoporation using microbubble BR14 promotes pDNA/siRNA transduction to murine heart. Biochem Biophys Res Commun. 2005; 336: 118-27.
23. Zhigang W, Zhiyu L, Haitao R, Hong R, Qunxia Z, Ailong H, et al. Ultrasound-mediated microbubble destruction enhances VEGF gene delivery to the infarcted myocardium in rats. Clin Imaging. 2004; 28: 395-8.
24. Bekeredjian R, Chen S, Frenkel PA, Grayburn PA, Shohet RV. Ultrasound- targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation. 2003; 108: 1022-6.
25. Bekeredjian R, Grayburn PA, Shohet RV. Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine. J Am Coll Cardiol. 2005; 45: 329-35.
26. Shohet RV, Chen S, Zhou YT, Wang Z, Meidell RS, Unger RH, et al. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation. 2000; 101: 2554-6.
27. Chen S, Ding JH, Bekeredjian R, Yang BZ, Shohet RV, Johnston SA, et al. Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology. Proc Natl Acad Sci U S A. 2006; 103: 8469-74.
28. Chen S, Shimoda M, Wang MY, Ding J, Noguchi H, Matsumoto S, et al. Regeneration of pancreatic islets in vivo by ultrasound-targeted gene therapy. Gene Ther. 2010; 17: 1411-20.
29. Lan HY, Mu W, Tomita N, Huang XR, Li JH, Zhu HJ, et al. Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound- microbubble system in rat UUO model. J Am Soc Nephrol. 2003; 14: 1535-48.
30. Koike H, Tomita N, Azuma H, Taniyama Y, Yamasaki K, Kunugiza Y, et al. An efficient gene transfer method mediated by ultrasound and microbubbles into the kidney. J Gene Med. 2005; 7: 108-16.
31. Chen YC, Jiang LP, Liu NX, Wang ZH, Hong K, Zhang QP. P85, Optison microbubbles and ultrasound cooperate in mediating plasmid DNA transfection in mouse skeletal muscles in vivo. Ultrason Sonochem. 2011; 18: 513-9.
32. Kuliszewski MA, Kobulnik J, Lindner JR, Stewart DJ, Leong-Poi H. Vascular gene transfer of SDF-1 promotes endothelial progenitor cell engraftment and enhances angiogenesis in ischemic muscle. Mol Ther. 2011; 19: 895-902.
33. Wang X, Liang HD, Dong B, Lu QL, Blomley MJ. Gene transfer with microbubble ultrasound and plasmid DNA into skeletal muscle of mice: comparison between commercially available microbubble contrast agents. Radiology. 2005; 237: 224-9.
34. Zhang Q, Wang Z, Ran H, Fu X, Li X, Zheng Y, et al. Enhanced gene delivery into skeletal muscles with ultrasound and microbubble techniques. Acad Radiol. 2006; 13: 363-7.
35. Liao ZK, Tsai KC, Wang HT, Tseng SH, Deng WP, Chen WS, et al. Sonoporation-mediated anti-angiogenic gene transfer into muscle effectively regresses distant orthotopic tumors. Cancer Gene Ther. 2011.
36. Zhang Q, Wang Z, Ran H, Fu X, Li X, Zheng Y, et al. Enhanced gene delivery into skeletal muscles with ultrasound and microbubble techniques. Acad Radiol. 2006; 13: 363-7.
37. Leong-Poi H, Kuliszewski MA, Lekas M, Sibbald M, Teichert-Kuliszewska K, Klibanov AL, et al. Therapeutic arteriogenesis by ultrasound-mediated VEGF165 plasmid gene delivery to chronically ischemic skeletal muscle. Circ Res. 2007; 101: 295-303.
38. Haag P, Frauscher F, Gradl J, Seitz A, Schafer G, Lindner JR, et al. Microbubble- enhanced ultrasound to deliver an antisense oligodeoxynucleotide targeting the human androgen receptor into prostate tumours. J Steroid Biochem Mol Biol. 2006; 102: 103-13.
39. Nie F, Xu HX, Lu MD, Wang Y, Tang Q. Anti-angiogenic gene therapy for hepatocellular carcinoma mediated by microbubble-enhanced ultrasound exposure: an in vivo experimental study. J Drug Target. 2008; 16: 389-95.
40. Wang JF, Wang JB, Chen H, Zhang CM, Liu L, Pan SH, et al. Ultrasound- mediated microbubble destruction enhances gene transfection in pancreatic cancer cells. Adv Ther. 2008; 25: 412-21.
41. Chen ZY, Liang K, Qiu RX. Targeted gene delivery in tumor xenografts by the combination of ultrasound-targeted microbubble destruction and polyethylenimine to inhibit survivin gene expression and induce apoptosis. J Exp Clin Cancer Res. 2011; 29: 152.
42. Sirsi SR, Hernandez SL, Zielinski L, Blomback H, Koubaa A, Synder M, et al. Polyplex-microbubble hybrids for ultrasound-guided plasmid DNA delivery to solid tumors. J Control Release. 2012; 157-224-34.
43. Liang HD, Tang J, Halliwell M. Sonoporation, drug delivery, and gene therapy. Proc Inst Mech Eng H. 2010; 224: 343-61.
44. van Wamel A, Kooiman K, Harteveld M, Emmer M, ten Cate FJ, Versluis M, et al. Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation. J Control Release. 2006; 112: 149-55.
45. Schlicher RK, Radhakrishna H, Tolentino TP, Apkarian RP, Zarnitsyn V, Prausnitz MR. Mechanism of intracellular delivery by acoustic cavitation. Ultrasound Med Biol. 2006; 32: 915-24.
46. Deng CX, Sieling F, Pan H, Cui J. Ultrasound-induced cell membrane porosity. Ultrasound Med Biol. 2004; 30: 519-26.
47. Mehier-Humbert S, Bettinger T, Yan F, Guy RH. Plasma membrane poration induced by ultrasound exposure: implication for drug delivery. J Control Release. 2005; 104: 213-22.
48. Moosavi Nejad S, Hosseini SH, Akiyama H, Tachibana K. Optical observation of cell sonoporation with low intensity ultrasound. Biochem Biophys Res Commun. 2011; 413: 218-23.
49. Zhou Y, Kumon RE, Cui J, Deng CX. The size of sonoporation pores on the cell membrane. Ultrasound Med Biol. 2009; 35: 1756-60.
50. Tran TA, Roger S, Le Guennec JY, Tranquart F, Bouakaz A. Effect of ultrasound-activated microbubbles on the cell electrophysiological properties. Ultrasound Med Biol. 2007; 33: 158-63.
51. Hassan MA, Campbell P, Kondo T. The role of Ca(2+) in ultrasound- elicited bioeffects: progress, perspectives and prospects. Drug Discov Today. 2010; 15: 892-906.
52. Zhou Y, Yang K, Cui J, Ye JY, Deng CX. Controlled permeation of cell membrane by single bubble acoustic cavitation. J Control Release. 2011; 157: 103-11.
53. Caskey CF, Stieger SM, Qin S, Dayton PA, Ferrara KW. Direct observations of ultrasound microbubble contrast agent interaction with the microvessel wall. J Acoust Soc Am. 2007; 122: 1191-200.
54. Chen H, Kreider W, Brayman AA, Bailey MR, Matula TJ. Blood vessel deformations on microsecond time scales by ultrasonic cavitation. Phys Rev Lett. 2011; 106: 034301.
55. Dayton PA, Allen JS, Ferrara KW. The magnitude of radiation force on ultrasound contrast agents. J Acoust Soc Am. 2002; 112: 2183-92.
56. Hauser J, Ellisman M, Steinau HU, Stefan E, Dudda M, Hauser M. Ultrasound enhanced endocytotic activity of human fibroblasts. Ultrasound Med Biol. 2009; 35: 2084-92.
57. Meijering BD, Juffermans LJ, van Wamel A, Henning RH, Zuhorn IS, Emmer M, et al. Ultrasound and microbubble-targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation. Circ Res. 2009; 104: 679-87.
58. Lentacker I, Wang N, Vandenbroucke RE, Demeester J, De Smedt SC, Sanders NN. Ultrasound exposure of lipoplex loaded microbubbles facilitates direct cytoplasmic entry of the lipoplexes. Mol Pharm. 2009; 6: 457-67.
59. Geers B, Lentacker I, Alonso A, Sanders NN, Demeester J, Meairs S, et al. Elucidating the mechanisms behind sonoporation with adeno-associated virus-loaded microbubbles. Mol Pharm. 2011; 8: 2244-51.
60. Kimmel E. Cavitation bioeffects. Crit Rev Biomed Eng. 2006; 34: 105-61.
61. Caskey CF, Qin S, Dayton PA, Ferrara KW. Microbubble tunneling in gel phantoms. J Acoust Soc Am. 2009; 125: EL183-9.
62. Arvanitis CD, Bazan-Peregrino M, Rifai B, Seymour LW, Coussios CC. Cavitation-enhanced extravasation for drug delivery. Ultrasound Med Biol. 2011;37: 1838-52.
63. Lum AF, Borden MA, Dayton PA, Kruse DE, Simon SI, Ferrara KW. Ultrasound radiation force enables targeted deposition of model drug carriers loaded on microbubbles. J Control Release. 2006; 111: 128-34.
64. Lentacker I, De Geest BG, Vandenbroucke RE, Peeters L, Demeester J, De Smedt SC, et al. Ultrasound-responsive polymer-coated microbubbles that bind and protect DNA. Langmuir. 2006; 22: 7273-8.
65. Frenkel PA, Chen S, Thai T, Shohet RV, Grayburn PA. DNA-loaded albumin microbubbles enhance ultrasound-mediated transfection in vitro. Ultrasound Med Biol. 2002; 28: 817-22.
66. Lentacker I, Geers B, Demeester J, De Smedt SC, Sanders NN. Design and evaluation of doxorubicin-containing microbubbles for ultrasound- triggered doxorubicin delivery: cytotoxicity and mechanisms involved. Mol Ther. 2010; 18: 101-8.
67. Bekeredjian R, Chen S, Grayburn PA, Shohet RV. Augmentation of cardiac protein delivery using ultrasound targeted microbubble destruction. Ultrasound Med Biol. 2005; 31: 687-91.
68. Shimamura M, Morishita R. Naked plasmid DNA for gene therapy. Curr Gene Ther. 2011; 11.
69. Teupe C, Richter S, Fisslthaler B, Randriamboavonjy V, Ihling C, Fleming I, et al. Vascular gene transfer of phosphomimetic endothelial nitric oxide synthase (S1177D) using ultrasound-enhanced destruction of plasmid- loaded microbubbles improves vasoreactivity. Circulation. 2002; 105: 1104-9.
70. Chen Z, Xie M, Wang X, Lv Q, Ding S. Efficient gene delivery to myocardium with ultrasound targeted microbubble destruction and polyethylenimine. J Huazhong Univ Sci Technolog Med Sci. 2008; 28: 613-7.
71. Xenariou S, Griesenbach U, Liang HD, Zhu J, Farley R, Somerton L, et al. Use of ultrasound to enhance nonviral lung gene transfer in vivo. Gene Ther. 2007; 14: 768-74.
72. Borden MA, Caskey CF, Little E, Gillies RJ, Ferrara KW. DNA and polylysine adsorption and multilayer construction onto cationic lipid- coated microbubbles. Langmuir. 2007; 23: 9401-8.
73. Vandenbroucke RE, Lentacker I, Demeester J, De Smedt SC, Sanders NN. Ultrasound assisted siRNA delivery using PEG-siPlex loaded microbubbles. J Control Release. 2008; 126: 265-73.
74. Seemann S, Hauff P, Schultze-Mosgau M, Lehmann C, Reszka R. Pharmaceutical evaluation of gas-filled microparticles as gene delivery system. Pharm Res. 2002; 19: 250-7.
75. Hauff P, Seemann S, Reszka R, Schultze-Mosgau M, Reinhardt M, Buzasi T, et al. Evaluation of gas-filled microparticles and sonoporation as gene delivery system: feasibility study in rodent tumor models. Radiology. 2005; 236: 572-8.
76. Wang ZX, Wang ZG, Ran HT, Ren JL, Zhang Y, Li Q, et al. The treatment of liver fibrosis induced by hepatocyte growth factor-directed, ultrasound- targeted microbubble destruction in rats. Clin Imaging. 2009; 33: 454-61.
77. Zhou S, Li S, Liu Z, Tang Y, Wang Z, Gong J, et al. Ultrasound-targeted microbubble destruction mediated herpes simplex virus-thymidine kinase gene treats hepatoma in mice. J Exp Clin Cancer Res. 2011; 29: 170.
78. Li HL, Zheng XZ, Wang HP, Li F, Wu Y, Du LF. Ultrasound-targeted microbubble destruction enhances AAV-mediated gene transfection in human RPE cells in vitro and rat retina in vivo. Gene Ther. 2009; 16: 1146-53.
79. Xie W, Liu S, Su H, Wang Z, Zheng Y, Fu Y. Ultrasound microbubbles enhance recombinant adeno-associated virus vector delivery to retinal ganglion cells in vivo. Acad Radiol. 2010; 17: 1242-8.
80. Chen S, Shohet RV, Bekeredjian R, Frenkel P, Grayburn PA. Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction. J Am Coll Cardiol. 2003; 42: 301-8.
81. Muller OJ, Schinkel S, Kleinschmidt JA, Katus HA, Bekeredjian R. Augmentation of AAV-mediated cardiac gene transfer after systemic administration in adult rats. Gene Ther. 2008; 15: 1558-65.
82. Bish LT, Sweeney HL, Muller OJ, Bekeredjian R. Adeno-associated virus vector delivery to the heart. Methods Mol Biol. 2011; 807: 219-37.
83. Mehier-Humbert S, Yan F, Frinking P, Schneider M, Guy RH, Bettinger T. Ultrasound-mediated gene delivery: influence of contrast agent on transfection. Bioconjug Chem. 2007; 18: 652-62.
84. Nomikou N, Tiwari P, Trehan T, Gulati K, McHale AP. Studies on neutral, cationic and biotinylated cationic microbubbles in enhancing ultrasound- mediated gene delivery in vitro and in vivo. Acta Biomater. 2011.
85. Borden MA, Sarantos MR, Stieger SM, Simon SI, Ferrara KW, Dayton PA. Ultrasound radiation force modulates ligand availability on targeted contrast agents. Mol Imaging. 2006; 5: 139-47.
86. Borden MA, Zhang H, Gillies RJ, Dayton PA, Ferrara KW. A stimulus- responsive contrast agent for ultrasound molecular imaging. Biomaterials. 2008; 29: 597-606.
87. Chen CC, Borden MA. The role of poly(ethylene glycol) brush architecture in complement activation on targeted microbubble surfaces. Biomaterials. 2011; 32: 6579-87.
88. Chen CC, Sirsi SR, Homma S, Borden MA. Effect of surface architecture on in vivo ultrasound contrast persistence of targeted size-selected microbubbles. Ultrasound Med Biol. 2012; 38: 492-503.
89. Sirsi S, Feshitan J, Kwan J, Homma S, Borden M. Effect of microbubble size on fundamental mode high frequency ultrasound imaging in mice. Ultrasound Med Biol. 2010; 36: 935-48.
90. Streeter JE, Gessner R, Miles I, Dayton PA. Improving sensitivity in ultrasound molecular imaging by tailoring contrast agent size distribution: in vivo studies. Mol Imaging. 2010; 9: 87-95.
91. Tung YS, Vlachos F, Feshitan JA, Borden MA, Konofagou EE. The mechanism of interaction between focused ultrasound and microbubbles in blood-brain barrier opening in mice. J Acoust Soc Am. 2011; 130: 3059-67.
92. Kooiman K, Foppen-Harteveld M, van der Steen AF, de Jong N. Sonoporation of endothelial cells by vibrating targeted microbubbles. J Control Release. 2011; 154: 35-41.
93. Ferrara K, Pollard R, Borden M. Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. Annu Rev Biomed Eng. 2007; 9: 415-47.
94. Coussios CC, Roy RA. Applications of Acoustics and Cavitation to Noninvasive Therapy and Drug Delivery. Annual Review of Fluid Mechanics. 2008; 40: 395-420.
95. Krasovitski B, Frenkel V, Shoham S, Kimmel E. Intramembrane cavitation as a unifying mechanism for ultrasound-induced bioeffects. Proc Natl Acad Sci USA. 2011; 108: 3258-63.
96. Israelachvili JN. Intermolecular and Surface Forces. New York: Academic Press; 2011.